当前位置:
X-MOL 学术
›
Nat. Rev. Clin. Oncol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Darolutamide combo is a sensible option for mHSPC
Nature Reviews Clinical Oncology ( IF 81.1 ) Pub Date : 2022-03-08 , DOI: 10.1038/s41571-022-00616-2 Annette Fenner 1
中文翻译:
Darolutamide 组合是 mHSPC 的明智选择
更新日期:2022-03-08
Nature Reviews Clinical Oncology ( IF 81.1 ) Pub Date : 2022-03-08 , DOI: 10.1038/s41571-022-00616-2 Annette Fenner 1
Affiliation
中文翻译:
Darolutamide 组合是 mHSPC 的明智选择